Arden Trust CO Bristol Myers Squibb CO Transaction History

Arden Trust CO

$683 Million
Q2 2024

A detailed history of Arden Trust CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Arden Trust CO holds 13,257 shares of BMY stock, worth $780,439. This represents 0.08% of its overall portfolio holdings.

Number of Shares

13,257

Previous 17,378 23.71%

Holding current value

$780,439

Previous $942,000 41.61%

% of portfolio

0.08%

Previous 0.14%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 09, 2024	SELL	$40.25 - $52.99 $165,870 - $218,371	-4,121 Reduced 23.71%	13,257 $550,000
Q1 2024 Apr 03, 2024	SELL	$47.98 - $54.4 $9,739 - $11,043	-203 Reduced 1.15%	17,378 $942,000
Q4 2023 Jan 04, 2024	SELL	$48.48 - $57.85 $31,899 - $38,065	-658 Reduced 3.61%	17,581 $902,000
Q3 2023 Oct 10, 2023	SELL	$57.89 - $64.73 $21,824 - $24,403	-377 Reduced 2.03%	18,239 $1.06 Million
Q2 2023 Jul 14, 2023	SELL	$63.71 - $70.74 $8,664 - $9,620	-136 Reduced 0.73%	18,616 $1.19 Million
Q1 2023 Apr 14, 2023	SELL	$65.71 - $74.53 $5,979 - $6,782	-91 Reduced 0.48%	18,752 $1.3 Million
Q4 2022 Jan 20, 2023	SELL	$68.48 - $81.09 $5,478 - $6,487	-80 Reduced 0.42%	18,843 $0
Q3 2022 Oct 20, 2022	SELL	$0.13 - $76.84 $201 - $119,102	-1,550 Reduced 7.57%	18,923 $1.35 Million
Q2 2022 Jul 12, 2022	SELL	$72.62 - $79.98 $133,402 - $146,923	-1,837 Reduced 8.23%	20,473 $1.58 Million
Q1 2022 Apr 11, 2022	SELL	$61.48 - $73.72 $64,554 - $77,406	-1,050 Reduced 4.49%	22,310 $1.63 Million
Q4 2021 Jan 24, 2022	SELL	$53.63 - $62.52 $83,126 - $96,906	-1,550 Reduced 6.22%	23,360 $1.46 Million
Q3 2021 Oct 12, 2021	SELL	$59.17 - $69.31 $180,468 - $211,395	-3,050 Reduced 10.91%	24,910 $1.47 Million
Q2 2021 Jul 19, 2021	SELL	$61.91 - $67.42 $40,055 - $43,620	-647 Reduced 2.26%	27,960 $1.87 Million
Q1 2021 Apr 23, 2021	SELL	$59.34 - $66.74 $108,058 - $121,533	-1,821 Reduced 5.98%	28,607 $1.81 Million
Q4 2020 Jan 15, 2021	SELL	$57.74 - $65.43 $358,218 - $405,927	-6,204 Reduced 16.94%	30,428 $1.89 Million
Q3 2020 Oct 15, 2020	SELL	$57.43 - $63.64 $111,127 - $123,143	-1,935 Reduced 5.02%	36,632 $2.21 Million
Q2 2020 Jul 09, 2020	SELL	$54.82 - $64.09 $22,695 - $26,533	-414 Reduced 1.06%	38,567 $2.27 Million
Q1 2020 Apr 16, 2020	SELL	$46.4 - $67.43 $35,728 - $51,921	-770 Reduced 1.94%	38,981 $2.17 Million
Q4 2019 Jan 17, 2020	SELL	$49.21 - $64.19 $93,597 - $122,089	-1,902 Reduced 4.57%	39,751 $2.55 Million
Q3 2019 Oct 09, 2019	SELL	$42.77 - $50.71 $10,863 - $12,880	-254 Reduced 0.61%	41,653 $2.11 Million
Q2 2019 Jul 23, 2019	BUY	$44.62 - $49.34 $1.87 Million - $2.07 Million	41,907 New	41,907 $1.9 Million

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arden Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Arden Trust CO with notifications on news.

Account